Head-to-Head

Genprex, Inc. Common Stock vs. Eli Lilly & Co.

GNPX

Genprex, Inc. Common Stock

$3.37 -1.75%

VS LLY

Eli Lilly & Co.

$1152.44 +1.28%

Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 6 compared factors.

Size & Scale

GNPXLLY
Market Cap $2.81 million $1.03 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) $-16,498,565 $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

GNPXLLY
P/E Ratio — 38.69
Price / Book 0.19 30.32
Price / Sales — 12.89

GNPX leads on 1 of 1 valuation factors.

Profitability

GNPXLLY
Net Margin — 33.53%
Return on Equity -111.51% 78.84%

LLY leads on 1 of 1 profitability factors.

Dividend

GNPXLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

GNPX and LLY split the dividend factors evenly.

Risk & Sentiment

GNPXLLY
Short Interest 2.89% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: GNPX overview, GNPX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.